Interleukin 10

Interleukin 10 (IL-10) is a crucial cytokine with potent anti-inflammatory properties, playing a pivotal role in regulating the immune system. It helps maintain immune homeostasis by limiting excessive immune responses that could lead to tissue damage.

Interleukin 10

Key Takeaways

  • Interleukin 10 is a powerful anti-inflammatory cytokine produced by various immune cells.
  • Its primary role is to suppress immune responses, preventing autoimmunity and chronic inflammation.
  • IL-10 modulates the activity of T cells, B cells, macrophages, and dendritic cells.
  • Dysregulation of IL-10 is implicated in autoimmune diseases, infections, and cancer.
  • Current research explores IL-10 as a therapeutic agent for inflammatory conditions and a target in oncology.

What is Interleukin 10?

Interleukin 10 is a pleiotropic cytokine primarily known for its immunosuppressive and anti-inflammatory effects. Produced by a wide range of immune cells, including regulatory T cells (Tregs), macrophages, B cells, and dendritic cells, it acts as a critical regulator of the immune response. Its discovery in the late 1980s revealed a key mechanism by which the body prevents excessive or prolonged inflammation, which can be detrimental to tissues and organs.

This cytokine exerts its effects by binding to the Interleukin 10 receptor (IL-10R) found on the surface of various immune cells. This binding initiates intracellular signaling pathways that ultimately lead to the suppression of pro-inflammatory cytokine production and the inhibition of immune cell activation and proliferation. Understanding Interleukin 10 is fundamental to comprehending the delicate balance required for a healthy immune system.

Interleukin 10 Function and Immune Response

The interleukin 10 function and importance are vast, primarily centered on maintaining immune tolerance and preventing immunopathology. It plays a critical role in dampening immune responses after pathogens have been cleared or in situations where an immune response could cause more harm than good, such as in autoimmune conditions.

Key functions include:

  • Inhibition of Pro-inflammatory Cytokines: IL-10 suppresses the production of cytokines like TNF-α, IL-1β, IL-6, and IL-12, which are central to inflammatory processes.
  • Suppression of Antigen Presentation: It reduces the expression of MHC class II molecules and co-stimulatory molecules on antigen-presenting cells (APCs), thereby limiting T cell activation.
  • Regulation of T Cell Responses: IL-10 can inhibit T helper 1 (Th1) and Th17 cell responses, while promoting regulatory T cell (Treg) activity, which further contributes to immune suppression.
  • Modulation of Macrophage Activity: It shifts macrophages from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype, promoting tissue repair and resolution of inflammation.

The intricate role of interleukin 10 immune response regulation is vital for preventing autoimmune diseases and chronic inflammatory conditions. For instance, deficiencies or impaired signaling of IL-10 are often associated with increased susceptibility to inflammatory bowel diseases and other autoimmune disorders.

Current Research and Therapeutic Potential of Interleukin 10

Recent advancements in understanding Interleukin 10 have opened new avenues for therapeutic interventions. Interleukin 10 research updates consistently highlight its potential as a biotherapeutic agent for various inflammatory and autoimmune diseases. Researchers are exploring its use to dampen excessive immune activity in conditions such as rheumatoid arthritis, psoriasis, and multiple sclerosis. Clinical trials have investigated recombinant human IL-10 for its ability to reduce inflammation and improve patient outcomes.

Conversely, in the context of cancer, IL-10’s immunosuppressive properties can be a double-edged sword. While it can prevent immune-mediated damage, it can also hinder the body’s ability to mount an effective anti-tumor response. Therefore, current strategies in oncology often focus on modulating IL-10 pathways to enhance anti-tumor immunity, sometimes by blocking IL-10 or its receptor to unleash immune cells against cancer. The precise manipulation of IL-10 activity, either by administering exogenous IL-10 or by targeting its signaling pathways, remains a significant area of investigation, promising tailored treatments for a range of complex diseases.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.